133 related articles for article (PubMed ID: 37604227)
1. Lipid clearance and amyloid formation by serum amyloid A: exploring the links between beneficial and pathologic actions of an enigmatic protein.
Jayaraman S; Urdaneta A; Bullitt E; Fändrich M; Gursky O
J Lipid Res; 2023 Sep; 64(9):100429. PubMed ID: 37604227
[TBL] [Abstract][Full Text] [Related]
2. Synergy between serum amyloid A and secretory phospholipase A
Jayaraman S; Fändrich M; Gursky O
Elife; 2019 May; 8():. PubMed ID: 31111824
[TBL] [Abstract][Full Text] [Related]
3. Serum amyloid A self-assembles with phospholipids to form stable protein-rich nanoparticles with a distinct structure: A hypothetical function of SAA as a "molecular mop" in immune response.
Frame NM; Jayaraman S; Gantz DL; Gursky O
J Struct Biol; 2017 Dec; 200(3):293-302. PubMed ID: 28645735
[TBL] [Abstract][Full Text] [Related]
4. High-Density Lipoprotein (HDL) Counter-Regulates Serum Amyloid A (SAA)-Induced sPLA2-IIE and sPLA2-V Expression in Macrophages.
Zhu S; Wang Y; Chen W; Li W; Wang A; Wong S; Bao G; Li J; Yang H; Tracey KJ; D'Angelo J; Wang H
PLoS One; 2016; 11(11):e0167468. PubMed ID: 27898742
[TBL] [Abstract][Full Text] [Related]
5. Structural Basis for Vital Function and Malfunction of Serum Amyloid A: an Acute-Phase Protein that Wears Hydrophobicity on Its Sleeve.
Gursky O
Curr Atheroscler Rep; 2020 Sep; 22(11):69. PubMed ID: 32968930
[TBL] [Abstract][Full Text] [Related]
6. Human secretory phospholipase A2 mediates decreased plasma levels of HDL cholesterol and apoA-I in response to inflammation in human apoA-I transgenic mice.
Tietge UJ; Maugeais C; Lund-Katz S; Grass D; deBeer FC; Rader DJ
Arterioscler Thromb Vasc Biol; 2002 Jul; 22(7):1213-8. PubMed ID: 12117740
[TBL] [Abstract][Full Text] [Related]
7. Heparan sulfate promotes the aggregation of HDL-associated serum amyloid A: evidence for a proamyloidogenic histidine molecular switch.
Elimova E; Kisilevsky R; Ancsin JB
FASEB J; 2009 Oct; 23(10):3436-48. PubMed ID: 19549924
[TBL] [Abstract][Full Text] [Related]
8. Serum amyloid A protein enhances the activity of secretory non-pancreatic phospholipase A2.
Pruzanski W; de Beer FC; de Beer MC; Stefanski E; Vadas P
Biochem J; 1995 Jul; 309 ( Pt 2)(Pt 2):461-4. PubMed ID: 7542869
[TBL] [Abstract][Full Text] [Related]
9. Heparan sulfate dissociates serum amyloid A (SAA) from acute-phase high-density lipoprotein, promoting SAA aggregation.
Noborn F; Ancsin JB; Ubhayasekera W; Kisilevsky R; Li JP
J Biol Chem; 2012 Jul; 287(30):25669-77. PubMed ID: 22654109
[TBL] [Abstract][Full Text] [Related]
10. Comparison of lipid and lipid-associated cardiovascular risk marker changes after treatment with tocilizumab or adalimumab in patients with rheumatoid arthritis.
Gabay C; McInnes IB; Kavanaugh A; Tuckwell K; Klearman M; Pulley J; Sattar N
Ann Rheum Dis; 2016 Oct; 75(10):1806-12. PubMed ID: 26613768
[TBL] [Abstract][Full Text] [Related]
11. Serum amyloid A forms stable oligomers that disrupt vesicles at lysosomal pH and contribute to the pathogenesis of reactive amyloidosis.
Jayaraman S; Gantz DL; Haupt C; Gursky O
Proc Natl Acad Sci U S A; 2017 Aug; 114(32):E6507-E6515. PubMed ID: 28743750
[TBL] [Abstract][Full Text] [Related]
12. Modulation of immunity by the secreted phospholipase A
Murakami M; Sato H; Taketomi Y
Immunol Rev; 2023 Aug; 317(1):42-70. PubMed ID: 37035998
[TBL] [Abstract][Full Text] [Related]
13. Structural studies of a serum amyloid A octamer that is primed to scaffold lipid nanodiscs.
Nady A; Reichheld SE; Sharpe S
Protein Sci; 2024 May; 33(5):e4983. PubMed ID: 38659173
[TBL] [Abstract][Full Text] [Related]
14. Structure of serum amyloid A suggests a mechanism for selective lipoprotein binding and functions: SAA as a hub in macromolecular interaction networks.
Frame NM; Gursky O
FEBS Lett; 2016 Mar; 590(6):866-79. PubMed ID: 26918388
[TBL] [Abstract][Full Text] [Related]
15. Structural mechanism of serum amyloid A-mediated inflammatory amyloidosis.
Lu J; Yu Y; Zhu I; Cheng Y; Sun PD
Proc Natl Acad Sci U S A; 2014 Apr; 111(14):5189-94. PubMed ID: 24706838
[TBL] [Abstract][Full Text] [Related]
16. Secretory phospholipase A2, group IIA is a novel serum amyloid A target gene: activation of smooth muscle cell expression by an interleukin-1 receptor-independent mechanism.
Sullivan CP; Seidl SE; Rich CB; Raymondjean M; Schreiber BM
J Biol Chem; 2010 Jan; 285(1):565-75. PubMed ID: 19850938
[TBL] [Abstract][Full Text] [Related]
17. Effect of lipid environment on amyloid fibril formation of human serum amyloid A.
Tanaka M; Nishimura A; Takeshita H; Takase H; Yamada T; Mukai T
Chem Phys Lipids; 2017 Jan; 202():6-12. PubMed ID: 27865770
[TBL] [Abstract][Full Text] [Related]
18. Divergent effect of glycosaminoglycans on the in vitro aggregation of serum amyloid A.
Aguilera JJ; Zhang F; Beaudet JM; Linhardt RJ; Colón W
Biochimie; 2014 Sep; 104():70-80. PubMed ID: 24878279
[TBL] [Abstract][Full Text] [Related]
19. Heparin interactions with apoA1 and SAA in inflammation-associated HDL.
Digre A; Nan J; Frank M; Li JP
Biochem Biophys Res Commun; 2016 May; 474(2):309-314. PubMed ID: 27105909
[TBL] [Abstract][Full Text] [Related]
20. Role of serum amyloid A during metabolism of acute-phase HDL by macrophages.
Artl A; Marsche G; Lestavel S; Sattler W; Malle E
Arterioscler Thromb Vasc Biol; 2000 Mar; 20(3):763-72. PubMed ID: 10712402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
